FOLK
ACTRN12618001864213
Treatment
Not Applicable
Government body,National Health and Medical Research Council
Prof Rana Hinman
We are conducting a research study to compare the effects of daily use of motion-control and neutral walking shoes on lateral tibiofemoral osteoarthritis clinical outcomes, over 6 months. To do this we will randomly allocate participants to receive either i) motion-control or; ii) neutral walking shoes. Participants will be provided a pair of shoes from their allocated group, to be worn daily for 6 months (minimum of 6 hours/day).
i) aged 50 years or older; ii) report knee pain on most days of the past month; iii) report a minimum pain score of 4 on an 11-point numeric rating scale during walking over the previous week; iv) demonstrate Grade 2-4 tibiofemoral osteoarthritis on x-ray as determined by the Kellgren & Lawrence grading system; and v) demonstrate grade of lateral tibiofemoral joint space narrowing greater than medial tibiofemoral joint space narrowing according to a radiographic atlas (where Grade 0=no narrowing .... Read more
i) suffered knee pain for <3 months; ii) recent knee surgery (past 6 months) or planned surgery in next 6 months; iii) current use of shoe orthoses, customized shoes or ankle/knee braces; iv) current primary use of high heels, thongs or work boots that would restrict ability to wear study shoes 6 hours/day; v) had a hip or knee replacement on most painful knee; vi) had a high tibial osteotomy on most painful knee; vii) had any knee injections in the past 3 months or planned injections in next 6 .... Read more
No
Sample Size 40
Min. age 50 Years
Max. age No limit
Sex Both males and females
Condition category Knee Osteoarthritis
Condition code Musculoskeletal
Intervention code Treatment: Devices
This pragmatic comparative effectiveness trial will compare two different types of walking shoes manufactured by Asics. Following baseline assessment, participants will be randomly allocated to receive either i) motion-control or; ii) neutral walking shoes. Participants will be provided a pair of shoes from their allocated group, to be worn daily for 6 months (minimum of 6 hours/day), after which participants will be reassessed remotely via paper or web-based questionnaires. Motion-control shoes .... Read more
Control group Active
The comparator shoe will be the neutral walking shoes. These shoes have a mono-density mid-sole (i.e. equal medial and lateral stiffness).
Outcome: Severity of knee pain while walking Scored on an 11-point numerical rating scale (NRS) for average overall pain on walking in the last week. Timepoint: Baseline, and 6 months after randomization
yes
All data published in the results paper will be made available (Paterson KL, et al. BMJ Open 2022;12:e061627. doi:10.1136/bmjopen-2022-061627).
6/9/2022 - 6/9/2037 (a period of 15 years from publication)
Data will be made available to researchers as required for specific, approved analyses. Data will be provided from locked, cleaned, and de- identified study database. Requests will be reviewed by the Principal Investigator prior to approval.
The investigators endorse the concept of data sharing to advance medical science. All requests for data sharing will be reviewed by the Principal Investigator to ensure no conflict with any planned sub analyses and to ensure that the data are shared in an ethical and protected manner. Analyses aimed to improve treatment of knee osteoarthritis for non-commercial purposes are eligible.